AlphaCentric Life Sciences and Healthcare Fund Class A
LYFAX
NASDAQ
| Weiss Ratings | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Company Info | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | AlphaCentric Funds | |||
| Manager/Tenure (Years) | Ryan Dunnegan (0) | |||
| Website | http://www.AlphaCentricFunds.com. | |||
| Fund Information | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | AlphaCentric Life Sciences and Healthcare Fund Class A | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Nov 29, 2019 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.95% | |||
| Dividend | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.63% | |||
| Asset Allocation | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 5.57% | |||
| Stock | 94.43% | |||
| U.S. Stock | 80.49% | |||
| Non-U.S. Stock | 13.94% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.54% | |||
| 30-Day Total Return | 2.68% | |||
| 60-Day Total Return | 8.24% | |||
| 90-Day Total Return | 8.69% | |||
| Year to Date Total Return | 3.75% | |||
| 1-Year Total Return | -5.13% | |||
| 2-Year Total Return | 1.80% | |||
| 3-Year Total Return | 14.78% | |||
| 5-Year Total Return | 40.17% | |||
| Price | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $13.00 | |||
| 1-Month Low NAV | $12.65 | |||
| 1-Month High NAV | $13.43 | |||
| 52-Week Low NAV | $11.57 | |||
| 52-Week Low NAV (Date) | May 14, 2025 | |||
| 52-Week High NAV | $14.15 | |||
| 52-Week High Price (Date) | Sep 19, 2024 | |||
| Beta / Standard Deviation | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.82 | |||
| Standard Deviation | 20.88 | |||
| Balance Sheet | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 33.41M | |||
| Operating Ratios | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.71% | |||
| Turnover Ratio | 164.00% | |||
| Performance | LYFAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 17.49% | |||
| Last Bear Market Total Return | -11.88% | |||